Telehealth support for young cancer patients to preserve fertility

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a multi-component telehealth intervention designed to enhance engagement in oncofertility care among adolescent and young adult cancer patients. The intervention aims to provide tailored support and resources to help these patients make informed decisions regarding fertility preservation. By observing the implementation of this intervention, the study seeks to determine its effectiveness in improving patient outcomes in oncofertility care. The researchers hypothesize that increased engagement will lead to better alignment with patients' fertility goals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Newly diagnosed cancer or cancer relapse
* Primary language English or Spanish
* Receiving oncology care at participating clinical sites
* Ages 0 to 42 years if female
* Ages 0 to 50 years if male

Exclusion Criteria:

* Non-melanoma skin cancer, because primary treatment is excision with no infertility risk
* Metastatic/Stage IV non-thyroid solid tumors, because of poor prognosis

Where it's running

• City of Hope
  Duarte, California, United States Recruiting
• University of California San Diego
  La Jolla, California, United States Recruiting
• Rady Children's Hospital San Diego
  San Diego, California, United States Recruiting
• Cancer Resource Center of the Desert
  El Centro, California, United States Active not recruiting

Study contacts

• Principal investigator: H. Irene Su, MD, MSCE — University of California, San Diego
• Study coordinator: H. Irene Su, MD, MSCE
• Email: hisu@health.ucsd.edu
• Phone: 858-822-5986

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Follicular Flushing During Abdominal Egg Retrieval in Women with Low Egg Reserve

  This study tests whether rinsing the egg sacs during abdominal egg collection yields more eggs and more mature eggs for freezing in women with low ovarian reserve.

  Recruiting at 2 sites Centrum Clinic IVF Center · Ankara, Ankara and 1 other locations · NCT07877025

• GnRH agonist versus dual hCG/GnRH trigger for ovulation induction in fertility preservation

  We will test whether using a GnRH agonist alone or a dual trigger (GnRH agonist plus hCG) gives better egg retrieval numbers and safety for people with cancer doing egg freezing before gonadotoxic treatment.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07546136

• Combining ovarian tissue freezing with egg (oocyte) freezing versus egg freezing alone

  This research will test whether combining ovarian tissue freezing with egg freezing helps adult women with cancer preserve more fertility than egg freezing alone.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07546123

• Long-term follow-up of fertility preservation in women after cancer remission

  This project will see how fertility preservation options work long-term for women in remission from cancer or hematological disease, including how often preserved material is used and the psychological effects.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT07312058

• When to start hormones after stopping combined birth control for planned egg freezing

  This trial tests whether taking a two-month break from combined hormonal birth control versus starting ovarian stimulation immediately affects outcomes for ovary-bearing people aged 18–40 who are planning to freeze their eggs.

  Recruiting at 2 sites Shady Grove Fertility Reproductive Science Center · Orange, Connecticut and 2 other locations · NCT07225660

• Fertility-preserving hysteroscopic treatment outcomes for endometrial cancer and atypical hyperplasia

  This project tests whether removing lesions by hysteroscopy combined with hormonal therapy helps women with endometrial cancer or atypical hyperplasia preserve fertility and achieve good pregnancy and cancer-control outcomes.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07077876

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.